SuperLiving lands $7M Series A from Lightspeed to scale Tier II/III wellness play
Bengaluru-based AI preventive health D2C SuperLiving raised $7M Series A led by Lightspeed, with Kae Capital and All-in Capital. With 1.5M installs and 100,000 paying users — 73% from Tier II/III cities like Meerut, Agra, Varanasi — the brand will scale vernacular content, diagnostics and health commerce.
What happened
SuperLiving, a Bengaluru-based AI wellness and preventive health D2C platform targeting Tier II/III India, raised $7M Series A led by Lightspeed. Funds will
Key facts
- $7M Series A
- 1.5M installs
- 100,000 paying users
- 73% Tier II/III
Why this matters
SuperLiving's install-to-paid conversion across Tier II/III makes it a strategic distribution asset for diagnostics chains and pharma brands hunting non-metro health commerce rails.
What to watch
- Lightspeed or Kae follow-on rounds in adjacent vernacular health plays
- SuperLiving launching private-label supplements or chronic-care subscriptions
- HealthifyMe or Practo announcing Tier II/III specific product lines
- Diagnostics labs cutting B2B2C rates to D2C apps
- Insurance tie-ups (Star, Niva Bupa) for preventive bundles
- Map SuperLiving's vernacular content stack and diagnostics partners within 30 days
- Benchmark paying-user ARPU vs HealthifyMe and Cult.fit Tier II cohorts
- Track hiring signals on LinkedIn for regional GMs and clinical advisors
- Probe whether incumbents respond with Hindi/Marathi/Bhojpuri content sprints